Podcast
Questions and Answers
What is the primary consideration for deciding to use MHT and the type of formulation used?
What is the primary consideration for deciding to use MHT and the type of formulation used?
- Menopause onset and age
- Osteoporosis risk and sleep quality
- Personal preference and menopausal symptoms severity (correct)
- Urogenital symptoms and heart disease risk
What is the most effective treatment for moderate to severe vasomotor symptoms and impaired sleep quality?
What is the most effective treatment for moderate to severe vasomotor symptoms and impaired sleep quality?
- MHT, specifically estrogen only therapy (correct)
- MHT, specifically estrogen plus a progestogen or estrogen agonist/antagonist
- Intravaginal estrogen cream, tablet, or ring
- Ospemifene, a selective estrogen receptor modulator
When is intravaginal estrogen cream, tablet, or ring the preferred treatment option?
When is intravaginal estrogen cream, tablet, or ring the preferred treatment option?
- When urogenital symptoms are the only menopausal complaint (correct)
- When the patient has a history of hysterectomy
- When the patient has an intact uterus
- When the patient is at risk for osteoporosis related fractures
What is the benefit of intravaginal estrogen in reducing the risk of recurrent urinary tract infections?
What is the benefit of intravaginal estrogen in reducing the risk of recurrent urinary tract infections?
What is the benefit of estrogen only therapy in 50- to 59-year-old females with a history of hysterectomy?
What is the benefit of estrogen only therapy in 50- to 59-year-old females with a history of hysterectomy?
What is the indication for MHT in recently menopausal individuals at risk?
What is the indication for MHT in recently menopausal individuals at risk?